Psoriatic Arthritis Treatment Market by Drug Type (NSAIDs, DMARDs, Biologics, and Others), Type (Prescription, and OTC), and Route of Administration (Topical, Oral, and Injectable): Global Opportunity Analysis and Industry Forecast, 20192026
- Published Date: 2020-10-06
- Report ID: 1388
- Pages: 228
-
Format:
The psoriatic arthritis treatment market was valued at $7,860 million in 2018, and is estimated to reach at $13,744 million by 2026, registering a CAGR of 7.2% from 2019 to 2026.
Psoriatic arthritis is an autoimmune disease caused by an attack of bodys immune system on skin and joint. The disease is characterized by stiffness, swelling in the joints, and pain. Symmetric psoriatic arthritis, asymmetric psoriatic arthritis, spondylitis, distal psoriatic arthritis, and arthritis mutilans are the different types of psoriatic arthritis. Symptoms associated with this disorder include low back pain, conjunctivitis, swollen joint, nail pitting, and foot pain. The disorder is more prevalent among patients already suffering from psoriasis. Psoriatic arthritis can be diagnosed with tests such as rheumatoid factor (RF), joint fluid test, X-ray, and magnetic resonance imaging (MRI). Drugs used to treat psoriatic arthritis disease include NSAIDs, disease-modifying antirheumatic drugs (DMARDs), biologics, immunosuppressant drugs, and others.
Significant increase in prevalence of psoriatic arthritis, rise in demand for psoriatic arthritis pharmacotherapy, strong pipeline of biosimilar & biologic products, stressful lifestyle resulting in the overstimulation of immune system, and rise in geriatric population are the key factors that fuel the growth of the global psoriatic arthritis treatment market. Moreover, rise in adoption of psoriatic arthritis treatment medications, increase in R&D activities to develop new products for effective treatment of psoriatic arthritis, frequent product launches by key players, surge in awareness toward availability of treatment for psoriatic arthritis, and increase in risk of diseases are other factors that contribute toward the growth of the market. However, lack of standardization tools for diagnosis and high cost of treatment are expected to hamper the market growth.
The global psoriatic arthritis treatment market is segmented into drug type, type, route of administration, and region. By drug type, the market is categorized into NSAIDs, DMARDs, biologics, and others. On the basis of type, the market is divided into prescription, and OTC. According to route of administration, it is segregated into topical, oral, and injectable. Region wise, the market is studied across North America (U.S., Canada, and Mexico), Europe (Germany, France, the UK, Italy, Spain, and rest of Europe), Asia-Pacific (China, Japan, Australia, India, South Korea, and rest of Asia-Pacific), and LAMEA (Brazil, Saudi Arabia, South Africa and rest of LAMEA).
KEY BENEFITS FOR STAKEHOLDERS
The study provides an in-depth analysis of the market along with the current trends and future estimations to elucidate the imminent investment pockets.
It offers a quantitative analysis from 2018 to 2026, which is expected to enable the stakeholders to capitalize on the prevailing market opportunities.
A comprehensive analysis of all the geographical regions is provided to determine the existing opportunities.
The profiles and growth strategies of the key players are thoroughly analyzed to understand the competitive outlook of the global market.
KEY MARKET SEGMENTS
By Drug Type
NSAIDs
DMARDs
Biologics
Others
By Type
Prescription
OTC
By Route of Administration
Topical
Oral
Injectable
By Region
North America
o U.S.
o Canada
o Mexico
Europe
o Germany
o France
o UK
o Italy
o Spain
o Rest of Europe
Asia-Pacific
o Japan
o China
o Australia
o India
o South Korea
o Rest of Asia-Pacific
LAMEA
o Brazil
o Saudi Arabia
o South Africa
o Rest of LAMEA
LIST OF KEY PLAYERS PROFILED IN THE REPORT
AbbVie Inc.
Amgen Inc.
Bristol-Myers Squibb Company
Celgene Corporation
Eli Lilly And Company
Johnson & Johnson
Merck & Co Inc.
Novartis AG
Pfizer Inc.
UCB S.A.
LIST OF OTHER PLAYERS IN THE VALUE CHAIN (These players are not profiled in the report. The same will be included on request.)
F. Hoffmann-La Roche AG
Valeant Pharmaceuticals International, Inc.
Abbott Laboratories
Chapter 1: Introduction
1.1. Report Description
1.2. Key Benefits For Stakeholders
1.3. Key Market Segments
1.3.1. List of Key Players Profiled In The Report
1.4. Research Methodology
1.4.1. Secondary Research
1.4.2. Primary Research
1.4.3. Analyst Tools And Models
Chapter 2: Executive Summary
2.1. Key Findings of The Study
2.2. Cxo Perspective
Chapter 3: Market Overview
3.1. Market Definition And Scope
3.2. Key Findings
3.2.1. Top Investment Pockets
3.3. PorterS Five Force Analysis
3.4. Market Dynamics
3.4.1. Drivers
3.4.1.1. Rise In Prevalence of Psoriasis & Psoriatic Arthritis Disease
3.4.1.2. Increase In Number of Pipeline Drugs
3.4.1.3. Increase In Government Expenditure On Healthcare
3.4.2. Restraint
3.4.2.1. Poor Demand In Under Developed Countries
3.4.3. Opportunities
3.4.3.1. Growth Opportunities In Emerging Markets
3.4.4. Impact Analysis
Chapter 4: Psoriatic Arthritis Treatment Market, By Drug Type
4.1. Overview
4.1.1. Market Size And Forecast
4.2. Nsaids
4.2.1. Key Market Trends, Growth Factors, And Opportunities
4.2.2. Market Size And Forecast, By Region
4.2.3. Market Analysis, By Country
4.3. Dmards
4.3.1. Key Market Trends, Growth Factors, And Opportunities
4.3.2. Market Size And Forecast
4.3.3. Market Analysis, By Country
4.4. Biologics
4.4.1. Key Market Trends, Growth Factors, And Opportunities
4.4.2. Market Size And Forecast
4.4.3. Market Analysis, By Country
4.5. Others
4.5.1. Key Market Trends, Growth Factors, And Opportunities
4.5.2. Market Size And Forecast
4.5.3. Market Analysis, By Country
Chapter 5: Psoriatic Arthritis Treatment Market, By Type
5.1. Overview
5.1.1. Market Size And Forecast
5.2. Prescription
5.2.1. Market Size And Forecast, By Region
5.2.2. Market Analysis, By Country
5.3. Otc
5.3.1. Market Size And Forecast, By Region
5.3.2. Market Analysis, By Country
Chapter 6: Psoriatic Arthritis Treatment Market, By Route of Administration
6.1. Overview
6.1.1. Market Size And Forecast
6.2. Injectable
6.2.1. Market Size And Forecast, By Region
6.2.2. Market Analysis, By Country
6.3. Oral
6.3.1. Market Size And Forecast, By Region
6.3.2. Market Analysis, By Country
6.4. Topical
6.4.1. Market Size And Forecast, By Region
6.4.2. Market Analysis, By Country
Chapter 7: Psoriatic Arthritis Treatment Market, By Region
7.1. Overview
7.1.1. Market Size And Forecast
7.2. North America
7.2.1. Key Market Trends, Growth Factors, And Opportunities
7.2.2. Market Size And Forecast, By Country
7.2.2.1. U.S.
7.2.2.1.1. U.S. Psoriatic Arthritis Treatment Market, By Drug Type
7.2.2.1.2. U.S. Psoriatic Arthritis Treatment Market, By Type
7.2.2.1.3. U.S. Psoriatic Arthritis Treatment Market, By Route of Administration
7.2.2.2. Canada
7.2.2.2.1. Canada Psoriatic Arthritis Treatment Market, By Drug Type
7.2.2.2.2. Canada Psoriatic Arthritis Treatment Market, By Type
7.2.2.2.3. Canada Psoriatic Arthritis Treatment Market, By Route of Administration
7.2.2.3. Mexico
7.2.2.3.1. Mexico Psoriatic Arthritis Treatment Market, By Drug Type
7.2.2.3.2. Mexico Psoriatic Arthritis Treatment Market, By Type
7.2.2.3.3. Mexico Psoriatic Arthritis Treatment Market, By Route of Administration
7.2.3. North America Market Size And Forecast, By Drug Type
7.2.4. North America Market Size And Forecast, By Type
7.2.5. North America Market Size And Forecast, By Route of Administration
7.3. Europe
7.3.1. Key Market Trends, Growth Factors, And Opportunities
7.3.2. Market Size And Forecast, By Country
7.3.2.1. Germany
7.3.2.1.1. Germany Psoriatic Arthritis Treatment Market, By Drug Type
7.3.2.1.2. Germany Psoriatic Arthritis Treatment Market, By Type
7.3.2.1.3. Germany Psoriatic Arthritis Treatment Market, By Route of Administration7.3.2.2. France
7.3.2.2.1. France Psoriatic Arthritis Treatment Market, By Drug Type
7.3.2.2.2. France Psoriatic Arthritis Treatment Market, By Type
7.3.2.2.3. France Psoriatic Arthritis Treatment Market, By Route of Administration
7.3.2.3. Uk
7.3.2.3.1. Uk Psoriatic Arthritis Treatment Market, By Drug Type
7.3.2.3.2. Uk Psoriatic Arthritis Treatment Market, By Type
7.3.2.3.3. Uk Psoriatic Arthritis Treatment Market, By Route of Administration
7.3.2.4. Italy
7.3.2.4.1. Italy Psoriatic Arthritis Treatment Market, By Drug Type
7.3.2.4.2. Italy Psoriatic Arthritis Treatment Market, By Type
7.3.2.4.3. Italy Psoriatic Arthritis Treatment Market, By Route of Administration
7.3.2.5. Spain
7.3.2.5.1. Spain Psoriatic Arthritis Treatment Market, By Drug Type
7.3.2.5.2. Spain Psoriatic Arthritis Treatment Market, By Type
7.3.2.5.3. Spain Psoriatic Arthritis Treatment Market, By Route of Administration
7.3.2.6. Rest of Europe
7.3.2.6.1. Rest of Europe Psoriatic Arthritis Treatment Market, By Drug Type
7.3.2.6.2. Rest of Europe Psoriatic Arthritis Treatment Market, By Type
7.3.2.6.3. Rest of Europe Psoriatic Arthritis Treatment Market, By Route of Administration
7.3.3. Europe Market Size And Forecast, By Drug Type
7.3.4. Europe Market Size And Forecast, By Type
7.3.5. Europe Market Size And Forecast, By Route of Administration
7.4. Asia-Pacific
7.4.1. Key Market Trends, Growth Factors, And Opportunities
7.4.2. Market Size And Forecast, By Country
7.4.2.1. Japan
7.4.2.1.1. Japan Psoriatic Arthritis Treatment Market, By Drug Type
7.4.2.1.2. Japan Psoriatic Arthritis Treatment Market, By Type
7.4.2.1.3. Japan Psoriatic Arthritis Treatment Market, By Route of Administration
7.4.2.2. China
7.4.2.2.1. China Psoriatic Arthritis Treatment Market, By Drug Type
7.4.2.2.2. China Psoriatic Arthritis Treatment Market, By Type
7.4.2.2.3. China Psoriatic Arthritis Treatment Market, By Route of Administration
7.4.2.3. Australia
7.4.2.3.1. Australia Psoriatic Arthritis Treatment Market, By Drug Type
7.4.2.3.2. Australia Psoriatic Arthritis Treatment Market, By Type
7.4.2.3.3. Australia Psoriatic Arthritis Treatment Market, By Route of Administration
7.4.2.4. India
7.4.2.4.1. India Psoriatic Arthritis Treatment Market, By Drug Type
7.4.2.4.2. India Psoriatic Arthritis Treatment Market, By Type
7.4.2.4.3. India Psoriatic Arthritis Treatment Market, By Route of Administration
7.4.2.5. South Korea
7.4.2.5.1. South Korea Psoriatic Arthritis Treatment Market, By Drug Type
7.4.2.5.2. South Korea Psoriatic Arthritis Treatment Market, By Type
7.4.2.5.3. South Korea Psoriatic Arthritis Treatment Market, By Route of Administration
7.4.2.6. Rest of Asia-Pacific
7.4.2.6.1. Rest of Asia-Pacific Psoriatic Arthritis Treatment Market, By Drug Type
7.4.2.6.2. Rest of Asia-Pacific Psoriatic Arthritis Treatment Market, By Type
7.4.2.6.3. Rest of Asia-Pacific Psoriatic Arthritis Treatment Market, By Route of Administration
7.4.3. Asia-Pacific Market Size And Forecast, By Drug Type
7.4.4. Asia-Pacific Market Size And Forecast, By Type
7.4.5. Asia-Pacific Market Size And Forecast, By Route of Administration
7.5. Lamea
7.5.1. Key Market Trends, Growth Factors, And Opportunities
7.5.2. Market Size And Forecast, By Country
7.5.2.1. Brazil
7.5.2.1.1. Brazil Psoriatic Arthritis Treatment Market, By Drug Type
7.5.2.1.2. Brazil Psoriatic Arthritis Treatment Market, By Type
7.5.2.1.3. Brazil Psoriatic Arthritis Treatment Market, By Route of Administration
7.5.2.2. Saudi Arabia
7.5.2.2.1. Saudi Arabia Psoriatic Arthritis Treatment Market, By Drug Type
7.5.2.2.2. Saudi Arabia Psoriatic Arthritis Treatment Market, By Type
7.5.2.2.3. Saudi Arabia Psoriatic Arthritis Treatment Market, By Route of Administration
7.5.2.3. South Africa
7.5.2.3.1. South Africa Psoriatic Arthritis Treatment Market, By Drug Type
7.5.2.3.2. South Africa Psoriatic Arthritis Treatment Market, By Type
7.5.2.3.3. South Africa Psoriatic Arthritis Treatment Market, By Route of Administration
7.5.2.4. Rest of Lamea
7.5.2.4.1. Rest of Lamea Psoriatic Arthritis Treatment Market, By Drug Type
7.5.2.4.2. Rest of Lamea Psoriatic Arthritis Treatment Market, By Type
7.5.2.4.3. Rest of Lamea Psoriatic Arthritis Treatment Market, By Route of Administration
7.5.3. Lamea Market Size And Forecast, By Drug Type
7.5.4. Lamea Market Size And Forecast, By Type
7.5.5. Lamea Market Size And Forecast, By Route of Administration
Chapter 8: Company Profiles
8.1. Abbvie Inc.
8.1.1. Company Overview
8.1.2. Company Snapshot
8.1.3. Operating Business Segments
8.1.4. Product Portfolio
8.1.5. Business Performance
8.1.6. Key Strategic Moves And Developments
8.2. Amgen Inc.
8.2.1. Company Overview
8.2.2. Company Snapshot
8.2.3. Operating Business Segments
8.2.4. Product Portfolio
8.2.5. Business Performance
8.2.6. Key Strategic Moves And Developments
8.3. Bristol-Myers Squibb Company
8.3.1. Company Overview
8.3.2. Company Snapshot
8.3.3. Operating Business Segments
8.3.4. Product Portfolio
8.3.5. Business Performance
8.3.6. Key Strategic Moves And Developments
8.4. Eli Lilly And Company.
8.4.1. Company Overview
8.4.2. Company Snapshot
8.4.3. Operating Business Segments
8.4.4. Product Portfolio
8.4.5. Business Performance
8.4.6. Key Strategic Moves And Developments
8.5. Johnson & Johnson.
8.5.1. Company Overview
8.5.2. Company Snapshot
8.5.3. Operating Business Segments
8.5.4. Product Portfolio
8.5.5. Business Performance
8.5.6. Key Strategic Moves And Developments
8.6. Merck & Co Inc.
8.6.1. Company Overview
8.6.2. Company Snapshot
8.6.3. Operating Business Segments
8.6.4. Product Portfolio
8.6.5. Business Performance
8.7. Mylan N.V
8.7.1. Company Overview
8.7.2. Company Snapshot
8.7.3. Operating Business Segments
8.7.4. Product Portfolio
8.7.5. Business Performance
8.8. Novartis Ag
8.8.1. Company Overview
8.8.2. Company Snapshot
8.8.3. Operating Business Segments
8.8.4. Product Portfolio
8.8.5. Business Performance
8.9. Pfizer Inc.
8.9.1. Company Overview
8.9.2. Company Snapshot
8.9.3. Operating Business Segments
8.9.4. Product Portfolio
8.9.5. Business Performance
8.10. Ucb S.A.
8.10.1. Company Overview
8.10.2. Company Snapshot
8.10.3. Operating Business Segments
8.10.4. Product Portfolio
8.10.5. Business Performance
Call Us
( India toll free )
+91 835 605 0278
( US toll free )
+1 800 601 6071
Drop us an email at
sales@prudentmarkets.com
Get your pre and post sales queries resolved by our Subject matter experts.
We will assist you to customize the report to fit your research needs.
Our prime focus is to provide qualitative and accurate data.
Feel free to order a sample report before purchase.
Your personal and confidential information is safe and secured.
